Sequential Studies of Complement Activation in Systemic Lupus Erythematosus

References

• Aarden L A., deGrot E R., Feltkamp T E. W. Chrithidialuciliae, a simple substrate for the determination of anti-dsDNA with immunofluorescence technique. Ann NY Acad Sci 1975; 254: 505
   PubMed Web of Science ®Google Scholar
• Abrass C K., Nies K M., Louie J S., Border W A., Glassock R J. Correlation and predictive accuracy of circulating immune complexes with disease activity in patients with systemic lupus erythematosus. Arth Rheum 1980; 23: 273
   PubMedGoogle Scholar
• Bourke B E., Moss I K., Maini R N. Measurement of the complement C3 breakdown product C3d by rocket immunoelectrophoresis. J Immunol. Methods 1982; 48: 91
   Web of Science ®Google Scholar
• Brandslund I, Sierstad H C., Svehag H C., Teisner B. Dqjjble-decker rocket immunoelectrophoresis for direct quantitation of complement C3 split products with C3d specificities in plasma. J Immunol Methods 1981; 44: 63
   PubMed Web of Science ®Google Scholar
• Cameron J S., Lessof M H., Ogg C S., Williams B D., Williams D G. Disease activity in nephritis of systemic lupus erythematosus in relation to serum complement concentrations. DNA-binding capacity and precipitating anti-DNA antibody. Clin Exp Immunol 1976; 25: 418
   PubMed Web of Science ®Google Scholar
• Cohen A S., Reynolds W E., Franklin C E., Kulka E C., Ropes M W., Schulman L E., Wallace S L. Preliminary criteria for the classification of systemic lupus erythematosus. Bull rheum Dis 1971; 21: 643
   Google Scholar
• Cooper N R., Nemerow G R., Mayes J T. Methods to detect and quantitate complement activation. Springer Semin. Immunopathol. 1983; 6: 195
   PubMed Web of Science ®Google Scholar
• Davis P, Cummig R H., Verrier-Jones J. Relationship between anti-DNA antibodies, complement consumption and circulating immune complexes in systemic lupus erythematosus. Clin Exp Immunol 1977; 28: 226
   PubMed Web of Science ®Google Scholar
• Fiedler A H. L., Walport M J., Batchelor J R., Rynes R I., Black C M., Dodi I A., Hughes G R. V. Family study of the major histocompatibility complex in patients with systemic lupus erythematosus: importance of null alleles of C4A and C4B in determining disease susceptibility. Brit Med J 1983; 286: 425
   PubMedGoogle Scholar
• Gewurz A, Lint T F., Roberts J L., Zeits H, Gewurz H. Homozygous C2 deficiency with fulminant lupus erythematosus. Severe nephritis via the alternative complement pathway. Arfh Rheum 1978; 21: 28
   PubMed Web of Science ®Google Scholar
• Johnson U, Holmström E. C3 fragmentation in human serum: formation of a mixed disulphide between C3d and albumin. Acta Path Microbiol Immunol Scand, Sect. C 1982; 90: 321–6
   Google Scholar
• Johnson U. Influence of ageing and polyethyleneglycol on the quantitation of C3d/dg in plasma and serum. Acta Path Microbiol Immunol Scand, Sect C
   Google Scholar
• Laurell A-B., Mårtensson U, Sjöholm A G. Studies on C1 subcomponents in chronic urticaria and angioedema. Int Arch Allergy Appl Immunol 1977; 54: 434
   PubMedGoogle Scholar
• Laurell A-B., Mårtensson U, Sjöholm A G. The development of simple tests for C1q, C1r, C1s, C2 and properdin. Clinical Aspects on the Complement System, W Opferkuch, K Rother, D R. Schultz. Thieme, Stuttgart 1976; 12, Int. Symp., Bochum, 1976
   Google Scholar
• Laurell A-B., Mårtensson U, Sjöholm A G. Quantitation of C1r-C1s-C1 inactivator complexes by electroimmunoassay. Acta Pathol Microbiol Immunol Scand, Sect. C, Immunol 1979; 87: 79
   Google Scholar
• Lightfoot R W., Hughes G R. V. Significance of persisting serological abnormalities in SLE. Arth Rheum 1976; 79: 837
   Google Scholar
• Lloyd W, Schur P. Immune complexes, complement and anti-DNA in exacerbations of systemic lupus erythematosus (SLE). Medicine 1981; 60: 208
   PubMed Web of Science ®Google Scholar
• Milgrom H, Curd J G., Kaplan R A., Miiller-Eberhard H J., Vaughan J H. Activation of the fourth component of complement (C4): assessment by rocket Immunoelectrophoresis and correlation with the metabolism of C4. J Immunol 1980; 124: 2780
   PubMed Web of Science ®Google Scholar
• Morrow W J. W., Williams D J. P., Ferec C, Casburn-Budd R, Isenberg D A., Paice E, Snaith M L., Youinou P, Le Goff P. The use of C3d as a means of monitoring clinical activity in systemic lupus erythematosus and rheumatoid arthritis. Ann Rheum Dis 1983; 42: 668
   PubMed Web of Science ®Google Scholar
• Pangburn M K., Schreiber R D., Miiller-Eberhard H J. Formation of the initial C3 convertase of the alternative complement pathway. Acquisition of C3b-like activities by spontaneous hydrolysis of the putative thioester in native C3. J Exp Med 1981; 154: 856
   PubMed Web of Science ®Google Scholar
• Perrin L H., Lambert P H., Miescher P A. Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis. J Clin Invest 1975; 56: 165
   PubMed Web of Science ®Google Scholar
• Petz L D., Powers R, Fries J R., Cooper N R., Holman H R. The in vivo metabolism of the third component of complement in systemic lupus erythematosus. Arth Rheum 1977; 20: 1304
   PubMedGoogle Scholar
• Schur P. Complement in lupus. Clin Rheum Dis 1975; 1: 519
   Google Scholar
• Schutte M, DiCamelli R, Murphy P, Sadove M, Gewurz H. Effects of anesthesia, surgery and inflammation upon host defence mechanisms. I. Effects upon the complement system. Int Arch Allergy Appl Immunol 1975; 48: 706
   PubMedGoogle Scholar
• Scullion M, Balint G, Whaley K. Evaluation of the C1q solid phase binding assay for immune complexes. A clinical and laboratory study. J Clin Lab Immunol 1979; 2: 5
   Google Scholar
• Siegel S. Nonparametric Statistics for the Behavioral Sciences. McGraw-Hill, New York 1956
   Google Scholar
• Sjöholm A G. Complemenet components in normal serum and plasma quantitated by electroimmunoassay. Scand J Immunol 1973; 4: 25
   Web of Science ®Google Scholar
• Sturfelt G, Sjöholm A G., Svensson B. Complement components, C1 activation and disease activity in SLE. Int Arch Allergy Appl Immunol 1983; 70: 12
   PubMedGoogle Scholar
• Sturfelt G, Sjöholm A G. Cleavage of C2 in pathological serum and plasma studied by crossed immuoelectrophoresis. Acta path, mikrobiol. Scand. Sect. C 1984; 92: 265
   Google Scholar
• Sturfelt G, Sjöholm A G. Complement components, complement activation and the acute phase response in systemic lupus erythematosus (SLE). Int Arch Allergy Appl Immunol 1984; 75: 75
   PubMedGoogle Scholar
• Swaak A J. G., Aarden L A., Statius van Eps L W., Feltkamp T E. W. Anti-dsDNA and complement profiles as prognostic guides in systemic lupus erythematosus. Arth Rheum 1979; 22: 226
   PubMed Web of Science ®Google Scholar
• Tan E M., Kunkel H G. Characteristics of a soluble nuclear antigen precipitating with sera of patients with sera of patients with systemic lupus erythematosus. J Immunol 1966; 96: 464
   PubMed Web of Science ®Google Scholar
• Tan E M., Cohen A S., Fries J F., Masi A T., McShane D J., Rothfield N F., Schaller J G., Talal N, Winchester R J. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arth Rheum 1982; 25: 1271
   PubMed Web of Science ®Google Scholar